Latest Board Appointments News

Hawsons Iron Limited has completed a pivotal Preliminary Feasibility Study and declared a massive 2.3 billion tonne Ore Reserve, setting the stage for a 26-year mine life producing premium magnetite concentrate.

Orbminco Limited has completed its acquisition of the Majestic North Gold Project and initiated an infill drilling program to boost resource confidence. The company also refreshed its leadership with new technical and board appointments as it charts a strategic path forward.

Iron Bear Resources has strengthened its financial position with fresh funding from Vale and a significant share sale, while progressing its flagship iron ore project in Canada amid positive government engagement.

Pathkey.AI has completed a strategic review, bolstered its leadership team, and secured $3.5 million in funding to accelerate growth and broaden its AI platform's applications beyond clinical trials.

Identitii Limited has secured five new customer contracts worth $250k and seen a four-fold increase in usage of its BNDRY platform, even as its capital raising efforts face delays due to a Takeovers Panel application.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Vital Metals has raised A$12.47 million in the second half of 2025 to fund its Tardiff Pre-Feasibility Study, underpinning the development of its high-grade rare earths project in Canada. The strong investor backing follows a robust July 2025 Scoping Study highlighting significant economic potential.

Besra Gold Inc has updated its Bau Gold Project resource estimate and is intensifying efforts to secure critical mining lease renewals, while restructuring its operations to sharpen capital discipline and technical oversight.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.

Lode Resources has reported a series of impressive high-grade silver and antimony drill results from its Montezuma Project in Tasmania, alongside completing a significant divestment of its Webbs Consol Silver Project, strengthening its balance sheet for further exploration.